{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-004345","form_type":"8-K","ticker":"BNGO","cik":"0001411690","company_name":"Bionano Genomics, Inc.","filed_at":"2023-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.828836+00:00","generated_at":"2026-06-20T00:54:47.795506+00:00","sec_items":["2.02","8.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"medium","headline":"Bionano guides FY2022 revenue $27.7-28M; updates TAM to $10B","bullets":["FY2022 revenue expected $27.7M-$28.0M; breakdown: 57% systems/consumables, 21% software, 22% services.","Geographic revenue: Americas 50%, APAC 17%, EMEA 33%.","TAM estimated at $10B annually, with $3B from cell bioprocessing QC opportunity.","Target markets include 10,000 labs and 1,400 therapeutics companies for OGM adoption."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-004345","json":"https://secwatch.observer/filing/0001140361-23-004345.json","markdown":"https://secwatch.observer/filing/0001140361-23-004345.md","text":"https://secwatch.observer/filing/0001140361-23-004345.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1411690/000114036123004345/0001140361-23-004345-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1411690/000114036123004345/brhc10047533_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T00:54:47.795506+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fec1be6b884a007e2b3b8d1bd0f4311dec325aff","claim":"Bionano Genomics, Inc. reported full year 2022 results: revenue $27.7 million and $28.0 million.","evidence_excerpt":"As previously announced on January 5, 2022, Bionano Genomics, Inc. (the “Company”), expects to report full year 2022 total revenue in the range of $27.7 million and $28.0 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1411690/000114036123004345/0001140361-23-004345-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2022"},{"label":"Revenue","value":"$27.7 million and $28.0 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}